Comparing high and low intensity supervised exercise interventions on energy compensation in overweight or obese women : a randomised parallel trial

niversity of Ottawa0 个研究点目标入组 21 人开始时间: 2019年1月4日最近更新: 2023年3月13日

试验速览

2019 Results article in https://pubmed.ncbi.nlm.nih.gov/31507431/ (added 27/02/2023)

•1. Pregnancy
•2. Smokers
•3. Drug users
•4. Consuming more than 2 units of alcohol per day
•5. Claustrophobic
•6. Use of nutritional supplements
•7. Not using oral contraceptives or hormones
•8. Diabetic (type 1 or type 2)
•9. Thyroid disorders
•10. Renal disease
•11. Liver disease
•12. Cancer
•13. Inflammatory disease
•14. Asthma
•15. Respiratory problems
•16. Cardiovascular disease
•17. Peripheral vascular disease
•18. Stroke
•19. Orthopaedic limitations
•20. Using any of the following:
•20.1. Systemic corticosteroids (e.g. prednisone)
•20.2. Anti-obesity agents (e.g. Xenical®, Meridia®)
•20.3. Natural supplemented for weight loss or weight control (e.g. Megace)
•20.4. Antipsychotics
•20.5. Mood stabilisers or antidepressants that have a significant impact on weight (e.g. Zyprexa®, Remeron®)
•20.6. Diuretics (e.g. Lasix®, furosemide)
•21. Treatment with thyroid hormones (stable dose for at least 3 months before the start of the study)
•22. Use of thiazide diuretics (hydrochlotozide) for less than 3 months

发起方

niversity of Ottawa